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Abstract
Introduction: There is a growing body of evidence that subtle deficits in instrumental activities of daily living
(IADL) may be present in mild cognitive impairment (MCI). However, it is not clear if there are IADL domains that
are consistently affected across patients with MCI. In this systematic review, therefore, we aimed to summarize
research results regarding the performance of MCI patients in specific IADL (sub)domains compared with persons
who are cognitively normal and/or patients with dementia.
Methods: The databases PsycINFO, PubMed and Web of Science were searched for relevant literature in December
2013. Publications from 1999 onward were considered for inclusion. Altogether, 497 articles were retrieved.
Reference lists of selected articles were searched for potentially relevant articles. After screening the abstracts of
these 497 articles, 37 articles were included in this review.
Results: In 35 studies, IADL deficits (such as problems with medication intake, telephone use, keeping
appointments, finding things at home and using everyday technology) were documented in patients with MCI.
Financial capacity in patients with MCI was affected in the majority of studies. Effect sizes for group differences
between patients with MCI and healthy controls were predominantly moderate to large. Performance-based
instruments showed slight advantages (in terms of effect sizes) in detecting group differences in IADL functioning
between patients with MCI, patients with Alzheimer’s disease and healthy controls.
Conclusion: IADL requiring higher neuropsychological functioning seem to be most severely affected in patients
with MCI. A reliable identification of such deficits is necessary, as patients with MCI with IADL deficits seem to have
a higher risk of converting to dementia than patients with MCI without IADL deficits. The use of assessment tools
specifically designed and validated for patients with MCI is therefore strongly recommended. Furthermore, the
development of performance-based assessment instruments should be intensified, as they allow a valid and reliable
assessment of subtle IADL deficits in MCI, even if a proxy is not available. Another important point to consider when
designing new scales is the inclusion of technology-associated IADL. Novel instruments for clinical practice should
be time-efficient and easy to administer.
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Introduction
Mild cognitive impairment (MCI) is a controversial
clinical entity, initially conceptualized as a transitional
zone between normal aging and dementia. The most
commonly used criteria for MCI—also known as Mayo
criteria—were proposed by Petersen et al. [1,2]. These
criteria require (1) a memory complaint, (2) normal ac-
tivities of daily living, (3) normal general cognitive func-
tion, (4) abnormal memory for age and (5) absence of
dementia. These criteria have been modified to expand
the original MCI concept, including impairments in
cognitive domains other than memory. Thus, the clin-
ical phenotypes of amnestic MCI and nonamnestic MCI
have been developed, which can both be further classi-
fied as single-domain or multiple-domain [3]. Discus-
sion about the MCI criteria and their operationalization
is ongoing [4], as the criteria neither specify methods to
assess cognitive or functional capacity nor provide cut-
off points for cognitive or functional scales to differenti-
ate MCI from mild dementia.
Another important point of discussion is the existence
of deficits in activities of daily living (ADL). ADL are
divided into basic activities of daily living (BADL) and
instrumental activities of daily living (IADL). BADL in-
clude self-maintenance skills such as bathing, getting
dressed or eating, and IADL consist of more complex
activities such as using public transportation, managing
finances, or shopping [5]. The assessment of ADL is
usually done by using rating scales, which are adminis-
tered either to the patient or a proxy. Controversy exists
about the ability of patients with MCI to adequately rate
themselves, as they lack awareness of IADL deficits and
overestimate their functional capacity [6-8]. Farias et al.,
however, reported no lack of awareness in patients with
MCI compared with healthy controls [9]. There is
evidence that proxies are not always a reliable source of
information, as they have a tendency to over- or under-
estimate IADL deficits [8,10,11]. In some cases, a proxy
is not available or has massive knowledge gaps. Direct
measures requiring the patient to solve specific IADL-
related tasks have better validity and do not have
reporter bias. However, they allow observation of only a
small excerpt of real-world performance and are quite
time-consuming.
It is assumed that IADL require more complex
neuropsychological processing capacity than BADL and
therefore are more prone to deterioration triggered by
cognitive decline [12,13]. Functional deficits have been
observed early in the course of decline [14-16]. In an
analysis of studies with a focus on BADL and IADL in
subjects with MCI, dementia or no cognitive deficits,
Nygård [17] suggested that IADL can be impaired before
the onset of dementia and should therefore be included
in the diagnosis of MCI.
These findings were taken into account by Winblad
et al. [18], who proposed the following criteria for MCI:
(1) not normal, not demented; (2) cognitive decline; and
(3) preserved BADL and/or minimal impairment in
complex instrumental functions. Thus, the criterion of
“normal activities of daily living” has been revised to a
less stringent one allowing for discrete IADL deficits in
patients with MCI.
Over the last 15 years, a large amount of research has
been conducted on IADL deficits in MCI. The aim of
the present review is to summarize research results re-
garding the performance of patients with MCI in specific
IADL (sub)domains compared with persons who are
cognitively normal and/or patients with dementia. In
addition, sample characteristics and applied IADL as-
sessment methods—performance-based instruments ver-
sus self- and/or informant-reported questionnaires or
interviews—are investigated.
Methods
Data sources
To identify relevant published papers, the electronic
databases PubMed, Web of Science and PsycINFO were
searched in December 2013. Publication dates were set
from January 1999 to December 2013. This restriction
was chosen to identify only papers that were published
after the introduction of Petersen’s MCI definition [2].
The search terms “mild cognitive impairment” (MeSH
term) or “MCI” were used in combination with the
terms “activities of daily living” (MeSH term) or “ADL”
or “instrumental activities of daily living” or “IADL” or
“everyday functioning” or “functional ability” or “func-
tional capability” or “functional deficits” or “functional
impairment.” After removal of duplicates, 497 articles
were retrieved from the 3 searched databases.
Selection criteria
Titles and abstracts of the retrieved articles were
screened by two authors (KJ and MD) independently
and were rated to assess their relevance to the research
question. If inconsistencies occurred, a third author
(LH) was consulted. The following selection criteria
were applied. (1) The abstract indicated that the focus
of the study was the investigation of IADL in MCI
versus healthy controls and/or dementia patients. (2)
General IADL and/or specific subdomains were investi-
gated. (3) The method of IADL assessment was stan-
dardized. (4) MCI was defined according to Petersen
and/or Winblad criteria [2,3,18]. (5) No other concepts,
such as cognitive impairment, no dementia [19,20], aging-
associated cognitive decline [21] or age-associated mem-
ory impairment [22], were used. (6) The original article
was written in English.
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Articles that met the outlined criteria were included in
the present review. Reference lists of the selected articles
were searched to retrieve further relevant articles. Effect
sizes (Cohen’s d) were calculated to allow a better evalu-
ation of clinical relevance.
Results
In total, 34 of the 497 papers were selected for review.
Owing to the broad focus of the search terms to ensure
retrieval of all relevant articles, the majority of articles
did not meet the inclusion criteria (that is, no definition
of MCI criteria, use of concepts other than Petersen
and/or Winblad criteria). A further three articles were
selected from among the reference lists of the selected
papers. Thus, the content of the present review is formed
from a total of 37 articles.
Mild cognitive impairment sample characteristics
For the diagnosis of MCI, the criteria of Petersen or
Winblad were applied across studies; their operationa-
lization, however, varied. One-third of the studies used
the original Petersen criteria supplemented by cutoffs on
specific neuropsychological tests [15,23-34]. In the re-
maining studies, the use of the original clinical criteria
published by Petersen et al. [2] was reported without
specific cutoff values or with a combination of Petersen
and Winblad criteria. Mean Mini Mental State Examin-
ation (MMSE) [35] scores ranged from 23.1 [36] to 28.7
points [37] for MCI samples, from 26.5 [36] to 29.4
points [30,38] for normal control samples and from
16.4 [39] to 25.5 points [40] for Alzheimer’s disease
(AD) samples. In each examined study, however, the
MMSE score for the MCI group was lower than that
for the comparative control group and higher than that
for the dementia sample.
Study types and/or designs
The majority of the reported studies followed a cross-
sectional design (29 studies [15,23-26,29,30,33,34,36-38,
40-56]), and eight studies applied a longitudinal design
[27,28,32,57-61]. In five of the longitudinal studies, risk
of conversion to AD depending on IADL impairment
was also assessed [27,28,32,58,60].
Assessment instruments used
Altogether, 31 different instruments were used to assess
IADL in patients with MCI (see Table 1 for details), includ-
ing performance-based instruments, self- and informant-
report rating questionnaires, and structured interviews.
Of the 37 studies, 15 relied solely on informant-report
rating questionnaires [23,28,29,31,33,40-43,45-48,54,58],
10 relied solely on performance-based assessments
[24,26,30,32,38,50-53,57] and 6 relied solely on self-report
rating instruments [27,36,55,56,59,61]. Three studies used
both informant-report questionnaires and performance-
based assessments [25,34,60]. Interestingly (and inconsist-
ently), in three studies [15,25,44], the IADL of patients with
MCI were rated by informants, whereas normal control
subjects rated their IADL functioning themselves.
Mild cognitive impairment subtypes
According to Petersen et al. [1], MCI has two major
subtypes: amnestic and nonamnestic. Both can be fur-
ther divided into single-domain and multidomain types.
Among the 37 studies included in this review, IADL
performance was analyzed between MCI subtypes in 8
studies [23,31,33,37,40,48,58,61].
Instrumental activities of living in patients with mild
cognitive impairment
Among the 37 studies included in this review, all but 2
studies [38,42] found IADL deficits in patients with MCI
compared with control subjects without cognitive impair-
ment on at least one applied instrument. In the following
sections, we first report results of studies investigating
global IADL (see Table 2), then results of studies in which
informant-report measures were used and studies using
self-report measures (see Table 3).
Global instrumental activities of daily living rating
instruments
Performance-based instruments
Schmitter-Edgecombe et al. [34] designed the Day-Out
Task (DOT), which requires multitasking in a real-world
setting. Participants have to prepare for a day out and
complete related tasks such as planning a bus route or
packing specific items in a picnic basket. Patients with
MCI required more time to complete the DOT than
healthy controls and made more errors while solving the
subtasks. By means of the Timed IADL, Wadley et al.
[50] investigated both the speed and accuracy of patients
with MCI in solving tasks related to shopping, finances,
medication, telephone use and locating information on
food labels. Patients with MCI took significantly longer
than normal controls to solve the tasks and were less ac-
curate. Using the Direct Assessment of Functional Status
(DAFS), Pereira et al. [60] found that patients with MCI
performed significantly worse than healthy controls and
better than AD patients. Financial and shopping skills
were the items that differentiated patients with MCI from
healthy controls. Binegar et al. [57] applied the Texas
Functional Living Scale and detected a significant but
small difference between patients with MCI and con-
trols. Interestingly, they mentioned that the perform-
ance of patients with MCI on this direct measure was
much better (47 points) than that of patients with mild
AD (31 points) in a previously conducted study [65].
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Table 1 Instruments used for instrumental activities of daily living assessmenta
Abbreviation Full instrument name Type IADL domains Psychometric properties
Performance-based assessment instruments
DAFS [62] Direct Assessment of Functional
Status
P 6 domains: time orientation,
communication, financial skills, shopping,
grooming, eating
Good interrater and test–retest reliability,
good evidence of discriminant and
convergent validity, ceiling effects for
time orientation, identify change and
shopping
DOT [34] Day-Out Task P 8 tasks to prepare a day out (including
packing a picnic basket, planning a bus
route, gathering correct change for bus
ride)
Interrater reliability: 96.92% agreement
EPT [63] Everyday Problems Test P Problem solving related to medication
use, meal preparation, telephone use,
shopping, financial management,
household management, transportation
Test–retest reliability: r = 0.93, internal
consistency (Cronbach’s α) = 0.88. Validity:
significant correlations with direct
observation of older adults’ performance
of everyday tasks (r = 0.67), older adults’
self-reports (r = 0.23) and dementia
patients’ self-reports (r = 0.36)
FCI [64] Financial Capacity Instrument P 7 domains: basic monetary skills, financial
conceptual knowledge, cash
transactions, checkbook management,
bank statement management, financial
judgment, bill payment
For all subdomains: test–retest
reliability r > 0.8, internal consistency
(Cronbach’s α) > 0.8
META [53] Management of Everyday
Technology Assessment
P 10 technology-related items (including
performing actions in a logical sequence,
turning a button)
Acceptable person response validity
TFLS [65] Texas Functional Living Scale P 5 domains: time/orientation, money,
communication, dressing, memory
Test–retest reliability: r = 0.93 in AD
sample, test–retest reliability in control
group: r = 0.52, strong correlation with
MMSE scores (r = 0.92)
TIADL [66] Timed Instrumental Activities of Daily
Living
P 5 domains: shopping, finances,
medication, telephone use, locating
information on food labels (speed and
accuracy)
Test–retest reliability: r = 0.85
UAB-DA [67] University of Alabama at
Birmingham Driving Assessment
P Real-world, standardized route: lane
control, gap judgment, turning,
maintaining proper speed, stopping
distance, signaling, obeying traffic signs,
preturn and postturn position, spacing,
steer steadiness, precrossing and
postcrossing position, and proper
scanning of driving space
Not reported
UCSD-UPSA [68] University of California San Diego
Performance-Based Skills Assessment
P 5 domains: household chores,
communication, finances, transportation,
planning recreational activities
Test–retest reliability: r = 0.92
VAPS [52] Virtual Action Planning Supermarket P Virtual reality supermarket, 8 parameters:
total distance, total time in seconds,
number of items purchased, number of
correct actions, number of incorrect
actions, number of pauses, combined
duration of pauses, time to pay
Validity (correlations between VAPS
performance and executive functions):
r = −0.40 to r = −0.63
Self-report and informant-report rating instruments
ADCS-ADL [69] Alzheimer’s Disease Cooperative
Study/Activities of Daily Living
Inventory
I 23 items (including shopping, hobbies,
personal appliances; both IADL and
BADL)
Moderate to good retest reliability, floor
effects for financial abilities in individuals
with dementia
ADCS-MCI-
ADL-18 [69]
18-item Alzheimer’s Disease
Cooperative Study/Activities of Daily
Living Inventory adapted for patients
with mild cognitive impairment
I 18 items (including shopping, hobbies,
personal appliances; both IADL and
BADL)
Not reported
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Table 1 Instruments used for instrumental activities of daily living assessmenta (Continued)
ADCS-MCI-
ADL-24 [45]
24-item Alzheimer’s Disease
Cooperative Study/Activities of Daily
Living scale adapted for patients
with mild cognitive impairment
I 24 items (original ADCS-MCI-ADL scale
plus 6 MCI-specific items, including
driving a car, organizing medication)
Not reported
ADL-PI [70] Activities of Daily Living-Prevention
Instrument
I 15 items (including completing and/or
organizing activities, taking medication,
using telephone, finding belongings,
managing finances)
Retest reliability: from r = 0.69 to r = 0.74
Bayer-ADL [71] Bayer Activities of Daily Living Scale I 25 items (2 BADL items, 18 specific IADL
items, 5 items for cognitive functions)
Internal consistency (Cronbach’s α > 0.98)
DAD [72] Disability Assessment for Dementia I IADL part with 23 items (meal
preparation, telephoning, going on an
outing, finances, medication, housework,
leisure) and BADL part with 17 items
Internal consistency (Cronbach’s α = 0.96),
interrater reliability (ICC = 0.95), test–
retest reliability (ICC = 0.96)
DAD-6 [40] 6-item Disability Assessment for
Dementia
I 6 items: meal preparation, telephoning,
going on an outing, handling finances
and correspondence, medication, leisure,
housework
Not reported
DHQ [59] Driving Habits Questionnaire S Driving difficulty in 8 different situations
and driving frequency
Retest reliability: from r = 0.65 to r = 0.86
for the 8 situations
ETUQ [56] Everyday Technology Use
Questionnaire
S 86 items (including questions about
technology at home and outside,
communication)
Acceptable levels of internal scale
validity, unidimensionality, and person
response validity
FAQ [73] Functional Activities Questionnaire S/I 10 items (including finances, shopping,
remembering appointments, playing
games, preparing a meal, traveling,
remembering appointments)
Not reported
FC-ADL [74] Functional Capacities for Activities of
Daily Living
I 50 statements reflecting possible IADL
difficulties
Not reported
4-IADL [27] 4 IADL scale items chosen from
Lawton and Brody’s Instrumental
Activities of Daily Living [5]
S 4 items: telephone use, finances,
medication, transportation
Not reported
9-IADL [58] 9-item IADL scale I 9 items: medication responsibility, ability
to buy food, to prepare meals, to keep
the home clean, to use the telephone, to
handle finances, to use public
transportation, to orientate oneself
outside, to visit people
Not reported
IQCODE [75] Informant Questionnaire on
Cognitive Decline in the Elderly
I 26 items (including finances,
communication, memory, household
appliances)
Cronbach’s α = 0.96, correlation with
MMSE (r = 0.74)
KI-IADL [34] Knowledgeable Informant report
about Instrumental Activities of Daily
Living
I 50 questions assessing 10 IADL domains:
using the phone, traveling, shopping,
preparing meals, household activities,
conversation, organization, social
functioning, medication management,
financial management
Not reported
L&B IADL [5] Lawton and Brody’s Instrumental
Activities of Daily Living
S/I 8 items: shopping, grooming, medication
responsibility, handling finances, mode
of transportation, telephone use, food
preparation, telephone use
Interrater correlation: r = 0.85
ROIL [76] Record of Independent Living I 37 items assessing 3 domains: activities,
communication, behavior
Not reported
SR-IADL [77] Self-report Instrumental Activities of
Daily Living
S Items include handling money, keeping
appointments, planning meals (IADL
performance and difficulty)
Reliability: r = 0.74
S-IADL [78] Seoul-Instrumental Activities of Daily
Living
S/I 15 items (including ability to prepare a
balanced meal, remember appointments,
ability to keep financial records,
remember to take medication)
Good reliability and validity
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Using the Naturalistic Action Task, Giovanetti et al.
[24] found that patients with MCI performed signifi-
cantly worse than healthy controls, but better than per-
sons with mild AD, on all three assessed tasks: preparing
toast and coffee, wrapping a gift and preparing a lunch
box. When cutoff scores were applied, no controls, but
24% of the patients with MCI and 76% of the AD group,
fell within the impaired range. Goldberg et al. found a
similar pattern of results when they applied a novel
performance-based assessment (the University of California
San Diego Performance-Based Skills Assessment): The
cognitively normal control group outperformed the MCI
group, which in turn performed better than the mild
to moderate AD group [25]. Interestingly, using the
informant-report Alzheimer’s Disease Cooperative Study/
Activities of Daily Living Inventory (ADCS-ADL), they
detected no significant differences between patients with
MCI and persons who were cognitively normal.
All of the performance-based instruments detected
significant differences in IADL functioning between pa-
tients with MCI and healthy controls, as well as between
patients with MCI and patients with dementia, respect-
ively. Furthermore, patients with MCI needed more time
to complete tasks than healthy controls and less time
than patients with dementia. Calculated effect sizes were
medium to large. In terms of effect sizes, the DAFS was
the best measure for detecting differences in global IADL
functioning between MCI and healthy controls (Cohen’s
d = 1.58) and between MCI and AD (Cohen’s d = 2.18).
Informant-report rating instruments
Using the Seoul-IADL, Ahn et al. [41] found deficits in
patients with MCI compared with healthy controls in
the domains of telephone use, meal preparation, me-
dication intake, management of belongings, keeping ap-
pointments, talking about recent events and performing
leisure activities and/or hobbies. They concluded that
IADL requiring memory or frontal cortex executive func-
tioning are at particular risk of decline in MCI. Jefferson
et al. [43] applied an error-based questionnaire of
functional capacity (FC-IADL). The FC-IADL measures
specific behaviors such as “getting lost in familiar places”
and “does not use tools for the proposed use.” On this
questionnaire, patients with MCI scored more than 1.5
standard deviations (SD) worse than normal controls. In
contrast, no statistically or clinically significant differences
were found for the informant-report Lawton and Brody
IADL scale.
In contrast, two other studies applying Lawton and
Brody’s IADL scale [44,45] showed that patients with MCI
had deficits compared with controls regarding shopping,
taking medications and handling finances.
Using the Record of Independent Living, Boeve et al.
[42] found no significant differences between patients
with MCI and healthy controls, but they did observe dif-
ferences between patients with MCI and controls com-
pared with dementia patients. This study is exceptional
within this review because the participants were 90 to
100 years of age. Furthermore, the MCI group was very
small (n = 13, compared with 56 healthy controls and 42
patients with dementia). Perneczky et al. [47] applied a
questionnaire specifically designed for measuring IADL
in MCI—the ADCS-MCI-ADL [69]—and found greater
informant-reported impairments for the MCI group than
among the age- and sex-matched cognitively normal
controls. Pedrosa et al. [45] also reported better ADCS-
MCI-ADL scores for healthy controls than for patients
with MCI. Consistent observations—that is, differences
between patients with MCI and healthy controls—in
both studies were observed for finding personal belong-
ings, balancing a checkbook, keeping appointments,
using a telephone and talking about recent events.
Furthermore, Pedrosa et al. compared the original ADCS-
MCI-ADL scale with an extended version. (The authors
added six items that they considered useful for MCI popu-
lations.) The 24-item version distinguished patients with
MCI and healthy controls more reliably than the 18-item
version [45]. Reppermund et al. [29], using the Bayer-ADL
scale, found significant differences between patients with
MCI and healthy controls. This effect was due to defi-
cits of patients with MCI in the domains of observing
important dates or events, reading, describing recent
Table 1 Instruments used for instrumental activities of daily living assessmenta (Continued)
SIB-R [79] Scales of Independent Behavior–
Revised
S/I 13 subscales organized into 4 adaptive
behavior clusters: (1) social interaction
and communication, (2) personal living,
(3) community living, (4) motor skills
Self-report: internal consistency
(Cronbach’s α) = 0.92, test–retest
reliability: r = 0.80
Informant-report: internal consistency
(Cronbach’s α) = 0.95, test–retest
reliability: r = 0.84
T-ADLQ [54] Technology–Activities of Daily Living
Questionnaire
I 7 subscales (self-care, household care,
employment and recreation, shopping
and money, travel, communication,
technology)
Cronbach’s α = 0.86; validity: significant
correlations with the MMSE (r = −0.70)
aAD, Alzheimer’s disease; ADL, Activities of daily living; BADL, Basic activities of daily living; I, Informant-report; IADL, Instrumental activities of daily living;
ICC, Intraclass correlation coefficient; MMSE, Mini Mental State Examination; P, Performance-based; S, Self-report.
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Table 2 Studies investigating global instrumental activities of daily living functioninga
Author Year MCI criteria Number
of subjects
Mean age, yr (SD) Mean MMSE
score (SD)
IADL measures used Results and effect sizes
(Cohen’s d)
Performance-based instruments
Binegar et al. [57] 2009 Petersen 30 MCI MCI 72.8 (7.9) MCI 27.3 (2.2) TFLS Total score: MCI < NC
(d = 0.61); subscales: significant
for memory subscale (d = 0.85),
but not for time/orientation,
money, communication,
dressing
Clinical 30 NC NC 73.7 (6.9) NC 29.2 (1.0)
ns significant
Giovannetti et al. [24] 2008 Petersen 25 MCI MCI 72.2 (6.7) MCI 27.6 (1.4) NAT Total score: NC >MCI > AD;
MCI versus NC: d = 1.05, MCI
versus AD: d = 1.46
Error score: NC < MCI < AD;
MCI versus NC: d = 0.74, MCI
versus AD: d = 1.78
1.5 SD below 18 NC NC 73.1 (3.2) NC 28.5 (1.0)
MMSE ≥25 25 mild AD AD 73.6 (3.8) AD 22.4 (2.8)
ns (NC = MCI) > AD, P < 0.05
Goldberg et al. [25] 2010 Petersen 26 MCI MCI 77.5 (7.1) MCI 26.1 (2.3) UCSD-UPSA UCSD-UPSA: NC >MCI > AD;
MCI versus NC: d = 0.86, MCI
versus AD: d = 1.81
ADCS-ADL: (NC =MCI ) > AD;
MCI versus AD: d = 1.81
1.5 SD below 50 NC NC 68.8 (9.9) NC 28.5 (1.5) Additional informant-report:
ADCS-ADL (NC: self-report)
CDR 0.5 22 AD AD 78.4 (5.4) AD 20.3 (3.4)
MMSE ≥24
Pereira [60] 2010 Petersen 31 MCI MCI 72.6 (7.0) MCI 27.3 (2.3) DAFS DAFS total score NC >MCI >
AD; MCI versus NC: d = 1.58,
MCI versus AD: d = 2.18
DAFS subdomains: NC > MCI
for finances and shopping, but
not time orientation,
communication, grooming,
eating, which were worse only
in AD;
IQCODE total score:
NC >MCI > AD; MCI versus NC:
d = 1.00, MCI versus AD:
d = 0.77
Clinical 32 NC NC 71.6 (5.6) NC 28.8 (1.5)
26 AD AD 77.9 (6.0) AD 19.5 (5.5) Additional informant-report:
IQCODE
AD > (MCI/NC) AD < (MCI = NC)
Schmitter-Edgecombe
et al. [34]
2012 Petersen 38 MCI MCI 70.5 (8.6) Not reported DOT DOT: MCI < NC for completion
time (d = 0.60) and accuracy
(d = 0.61)1.5 SD below 38 NC NC 69.3 (7.9) Additional informant-report:
KI-ADL
KI-ADL: MCI < NC (d = 0.50)
ns
Wadley et al. [50] 2008 Petersen 50 MCI MCI 70.0 (7.9) Not reported Timed IADL MCI = NC for accuracy
Clinical 59 NC NC 67.8 (7.1) MCI < NC for speed (d = 0.75),
significant subdomains
telephone (d = 0.56), grocery
(d = 0.75), medication (d =
0.51), nutrition information
(d = 0.52)
ns
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Table 2 Studies investigating global instrumental activities of daily living functioninga (Continued)
Informant-report rating instruments
Ahn et al. [41]. 2009 Petersen/Winblad 66 MCI MCI 70.8 (7.3) MCI 24.8 (3.1) Seoul-IADL MCI < NC (d = 1.62)
1.5 SD below 61 NC NC 64.4 (5.6) NC 27.6 (1.4)
CDR 0.5 significant
Boeve et al. [42] 2003 Petersen 13 MCI MCI 94.3 (2.6) MCI 26.8 (1.6) ROIL MCI = NC, MCI > dementia
(d = 2.93)
Clinical 56 NC NC 93.8 (2.5) NC 27.9 (2.3)
42 Dementia Dementia 94.8 (2.6) Dementia 18.6 (5.0)
ns AD < (MCI = NC)
Brown et al. [15] 2011 Petersen 394 MCI MCI 74.9 (7.4) MCI 27.0 (1.8) FAQ (NC: self-report) Severity of deficits: NC >MCI >
AD; MCI versus NC: d = 1.04,
MCI versus AD: d = 1.71
Number of deficits: NC < MCI
< AD; MCI versus NC: d = 1.28,
MCI versus AD: d = 1.62
1.5 SD below 229 NC NC 75.9 (5.0) NC 29.1 (1.0)
CDR 0.5 193 AD AD 75.3 (7.5) AD 23.3 (2.1)
MMSE ≥24 ns significant
Jefferson et al. [43] 2008 Petersen/Winblad 38 MCI MCI 74.6 (7.5) MCI 28.0 (1.7) L&B IADL L&B IADL: MCI = NC, FC-ADL:
MCI < NC (d = 0.84)
Clinical 39 NC NCI 72.4 (5.5) NC 29.3 (0.9) FC-ADL
ns significant
Mariani et al. [44] 2008 Petersen/Winblad 132 MCI MCI 76.1 (5.8) MCI 25.7 (1.6) L&B IADL(MCI: informant-
report, NC: self-report)
MCI < NC (d = 0.29)
below normality cutoff 249 NC NC 72.2 (7.5) NC 28.1 (1.2)
significant significant
Pedrosa et al. [45] 2010 Petersen/Winblad 30 MCI MCI 75.7 (6.4) MCI 24.4 (3.3) ADCS-MCI-ADL-18
ADCS-MCI-ADL-24
L&B-IADL
ADCS-MCI-ADL-18: NC >MCI >
AD; MCI versus NC: d = 1.39,
MCI versus AD: d = 2.27
ADCS-MCI-ADL-24: NC >MCI >
AD; MCI versus NC: d = 1.67,
MCI versus AD: d = 2.33
L&B IADL: NC > MCI > AD; MCI
versus NC: d = 2.0, MCI versus
AD: d = 2.89
1 SD below 31 NC NC 72.2 (8.0) NC 27.7 (3.0)
33 AD AD 76.1 (7.5) AD 16.5 (5.2)
Perneczky et al. [47] 2006 Petersen/Winblad 48 MCI MCI 69.2 (8.3) MCI 26.5 (2.3) ADCS-MCI-ADL-18
Bayer-ADL
IQCODE
ADCS-MCI-ADL-18: MCI < NC
(d = 1.98)
Bayer-ADL: MCI < NC (d = 1.95)
IQCODE: MCI < NC
(d = 1.09)
1 SD below 42 NC NC 66.7 (9.3) NC 29.3 (0.7)
CDR 0.5 ns significant
Perneczky et al. [46] 2006 Petersen/Winblad 45 MCI MCI 69.2 (8.3) MCI 26.9 (1.4) ADCS-MCI-ADL-18
Bayer-ADL
ADCS-MCI-ADL-18: MCI < NC
(d = 1.89)
Bayer-ADL: MCI < NC (d = 2.44)1 SD below 30 NC NC 66.7 (9.3) NC 29.3 (0.7)
CDR 0.5 ns
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Table 2 Studies investigating global instrumental activities of daily living functioninga (Continued)
Reppermund et al. [29] 2011 Petersen 293 MCI MCI 78.8 (4.7) MCI 28.0 (1.5) Bayer-ADL Bayer-ADL total: MCI < NC
(d = 0.32)1.5 SD below 469 NC NC 78.3 (4.7) NC 28.8 (1.2)
Bayer-ADL high cognitive
demand: MCI < NC (d = 0.40)
ns
Bayer-ADL low cognitive
demand: MCI = NC
Reppermund et al. [28] 2013 Petersen 227 MCI MCI 78.6 (4.4) MCI 28.3 (1.4) Bayer-ADL Bayer-ADL total: MCI < NC
(d = 0.39)1.5 SD below 375 NC NC 77.9 (4.6) NC 28.9 (1.2)
Bayer-ADL high cognitive
demand: MCI < NC (d = 0.40)
Bayer-ADL low cognitive
demand: MCI < NC (d = 0.27),
IADL performance at baseline
predicted conversion to
dementia at 2-year follow-up
ns significant
Self-report rating instruments
Kim et al. [36] 2009 Winblad 255 MCI MCI 72.0 (6.0) MCI 23.1 (4.5) Seoul-IADL MCI < NC (d = 0.27)
1 SD below 311 NC NC 70.7 (6.0) NC 26.5 (3.3)
significant significant
Peres et al. [27] 2006 Petersen 285 MCI Total sample: 80.8 (5.6) Not reported 4-IADL NC >MCI > dementia
1.5 SD below 828 NC
149 dementia
Comparison of MCI subtypes: informant-report rating instruments
Aretouli et al. [23] 2010 Petersen 124 MCI MCI 76.3 (7.5) MCI 28.2 (1.3) ADL-PI
IQCODE
ADL-PI: MCI < NC, P < 0.001; all
MCI subgroups < NC, P < 0.001,
md = sd; am = nonam
IQCODE: MCI < NC, P < 0.001;
true for all subgroups;
multiple > single, am = nonam
1.5 SD below (36 asMCI NC 72.4 (7.3) NC 29.3 (0.9)
CDR 0.5 45 amMCI significant significant
26 nasMCI
17 namMCI)
68 NC
Luck et al. [58] 2011 Winblad 161 MCI MCI 81.9 (5.0) Not reported 9 IADL items (Schneekloth
and Potthoff [80])
MCI < NC (aMCI = naMCI; aMCI
< NC (d = 0.17), naMCI = NC)
MCI + IADL deficits: higher risk
of conversion to dementia
MCI + IADL: 47.4% versus
MCI-IADL: 31.4%; NC + IADL:
26.7% versus NC-IADL: 8.0%
1 SD below (36 asMCI (aMCI 81.6 (4.8),
42 amMCI naMCI 82.2 (5.2))
60 nasMCI NC 81.2 (4.7)
23 namMCI) ns
723 NC
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Table 2 Studies investigating global instrumental activities of daily living functioninga (Continued)
de Rotrou [40] 2012 Petersen 53 MCI MCI 78.6 (7.3) MCI 26.2 (2.2) DAD-6 NC >MCI > AD; MCI versus NC:
d = 1.29, MCI versus AD:
d = 1.66
NC > sdMCI (d = 1.59), sdMCI >
mdMCI (d = 1.37)
Clinical (29 sdMCI NC 80.9 (4.2) NC 29.1 (1.0)
24mdMCI) Dementia 80.6 (6.2) Dementia 25.5 (1.8)
55 NC ns All significant
31 Dementia
Tam et al. [48] 2007 Petersen/Winblad 54 asMCI asMCI 79.3 (6.1) asMCI 25.4 (3.0) DAD IADL subscale: (NC = asMCI) >
amMCI > AD; amMCI versus
NC: d = 0.98, asMCI versus
amMCI: d = 0.80, asMCI versus
AD: d = 2.93, amMCI versus AD:
d = 1.71
CDR 0.5 93 amMCI amMCI 80.1 (6.5) amMCI 22.3 (3.1)
1 SD below 78 NC NC 77.1 (5.1) NC 27.2 (2.1)
85 AD AD 84.5 (5.9) AD 17.9 (3.2)
Teng et al. [31] 2010 Petersen 1108 MCI as 77.0 (9.2) as 27.8 (1.8) FAQ NC > asMCI/amMCI/nasMCI;
asMCI = amMCI, nasMCI =
namMCIMMSE ≥24 (532 asMCI am 75.3 (8.5) am 27.4 (1.8)
340 amMCI nas 74.1 (8.6) nas 28.2 (1.7)
162 nasMCI nam 73.0 (6.8) nam 27.8 (1.5)
74 namMCI) NC 74.8 (9.1) NC 29.0 (1.2)
3,036 NC significant
Yeh et al. [33] 2011 Petersen 56 asMCI asMCI 77.5 (6.7) asMCI 26.6 (1.6) DAD NC >MCI (as = am) > AD;
asMCI versus NC: d = 0.9,
amMCI versus NC: d = 1.06,
asMCI versus AD: d = 2.23,
amMCI versus AD: d = 1.9
1 SD below 94 amMCI amMCI 78.9 (5.8) amMCI 25.8 (1.6)
MMSE ≥24 64 NC NC 76.5 (6.6) NC 28.5 (1.3)
102 AD AD 79.6 (6.1) AD 20.9 (3.1)
Comparison of MCI subtypes: self-report rating instruments
Wadley et al. [61] 2007 Petersen/Winblad 84 aMCI aMCI 77.0 (7.0) aMCI 26.0 (1.9) IADL (Home Care
questionnaire)
IADL performance: aMCI/
mdMCI < NC, naMCI = NC;
aMCI versus NC: d = 0.23,
mdMCI versus NC: d = 0.31;
aMCI < naMCI: d = 0.23
IADL difficulty: all MCI
subgroups < NC; aMCI versus
NC: d = 0.57, naMCI versus NC:
d = 0.27, mdMCI versus NC:
d = 0.57; aMCI < naMCI: d = 0.23
1.5 SD below 171 naMCI naMCI 76.5 (6.2) naMCI 26.2 (2.1)
89 mdMCI mdMCI 78.8 (6.6) mdMCI 25.1 (1.8)
2,110 NC NC 72.9 (5.4) NC 27.6 (1.8)
significant
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Table 2 Studies investigating global instrumental activities of daily living functioninga (Continued)
Comparison of MCI subtypes and all three types of instruments
Burton et al. [37] 2009 Petersen/Winblad 6 asMCI asMCI 79.5 (5.7) asMCI 26.8 (2.5) Performance-based: EPT Self-report: SIB-R: NC >mdMCI
(d = 0.71), sdMCI >mdMCI
(d = 0.45), L&B: MCI = NC; L&B
IADL: MCI = NC
Informant-report SIB-R: NC >
sdMCI (d = 0.46), NC >mdMCI
(d = 0.51); L&B IADL: MCI = NC
EPT: NC > sdMCI >mdMCI;
sdMCI versus NC: d = 0.50,
sdMCI versus mdMCI: d = 1.54
1 SD below 39 nasMCI nasMCI 77.5 (5.6) nasMCI 28.7 (1.3) Self-report: L&B IADL, SIB-R;
Informant-report: L&B IADL,
SIB-R19 amMCI amMCI 82.0 (5.0) amMCI 28.2 (1.3)
28 namMCI namMCI 79.6 (4.9) namMCI 28.7 (1.1)
158 NC NC 73.6 (4.7) NC 28.9 (1.2)
aAD, Alzheimer’s disease; ADCS-ADL, Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory; ADCS-MCI-ADL-18, 18-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory
adapted for patients with mild cognitive impairment; ADCS-MCI-ADL-24, 24-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment; ADL,
Activities of daily living; ADL-PI, Activities of Daily Living-Prevention Instrument; am, Amnestic multiple domain; aMCI, Amnestic mild cognitive impairment; as, Amnestic single domain; BADL, Basic activities of daily
living; Bayer-ADL, Bayer Activities of Daily Living Scale; CDR, Clinical dementia rating; DAD, Disability Assessment for Dementia; DAD-6, 6-item Disability Assessment for Dementia; DAFS, Direct Assessment of Functional
Status; DHQ, Driving Habits Questionnaire; DOT, Day-Out Task; EPT, Everyday Problems Test; ETUQ, Everyday Technology Use Questionnaire; FAQ, Functional Activities Questionnaire; FC-ADL, Functional Capacities for
Activities of Daily Living; FCI, Financial Capacity Instrument; FC-IADL, Functional Capacities for Instrumental Activities of Daily Living; IADL, Instrumental activities of daily living; 4-IADL, 4-item Instrumental Activities of
Daily Living scale items chosen from Lawton and Brody; 9-IADL, 9-item Instrumental Activities of Daily Living scale; ICC, Intraclass correlation coefficient; IQCODE, Informant Questionnaire on Cognitive Decline in the
Elderly; KI-IADL, Knowledgeable Informant report about Instrumental Activities of Daily Living; L&B IADL, Lawton and Brody’s Instrumental Activities of Daily Living; MCI, Mild cognitive impairment; md, Multiple domain;
META, Management of Everyday Technology Assessment; MMSE, Mini Mental State Examination; nam, Nonamnestic multiple domain; naMCI, Nonamnestic mild cognitive impairment; nas, Nonamnestic single domain;
NAT, Naturalistic action task; NC, Normal control; NIA-AA, National Institute on Aging and Alzheimer’s Association; ns, nonsignificant; ROIL, Record of Independent Living; sd, Single domain; SD, Standard deviation;
S-IADL, Seoul-Instrumental Activities of Daily Living; SIB-R, Scales of Independent Behavior–Revised; SR-IADL, Self-report Instrumental Activities of Daily Living; TADL-Q, Technology–Activities of Daily Living
Questionnaire; TFLS, Texas Functional Living Scale; TIADL, Timed Instrumental Activities of Daily Living; UAB-DA, University of Alabama at Birmingham Driving Assessment; UCSD-UPSA, University of California, San Diego
Performance-Based Skills Assessment; VAPS, Virtual Action Planning Supermarket.
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Table 3 Studies investigating specific instrumental activities of daily living domainsa
Author Year MCI criteria Number
of subjects
Mean age,
yr (SD)
Mean MMSE
score (SD)
IADL measures Results and effect sizes
(Cohen’s d)
Financial capacity: performance-based instruments
Griffith et al. [26] 2003 Petersen 21 MCI MCI 68.1 (8.8) MCI 28.4 (1.2) FCI NC >MCI > AD; MCI versus
NC: d = 1.14, MCI versus AD
d = 1.21CDR 0.5 21 NC NC 66.7 (7.2) NC 29.3 (1.0)
22 AD AD 71.5 (9.2), ns AD 24.1 (2.6)
Sherod et al. [30] 2009 Petersen 113 MCI MCI 70.3 (7.4) MCI 28.1 (1.9) FCI NC >MCI > AD; MCI versus
NC: d = 1.03, MCI versus AD:
d = 0.871.5 SD
below
85 NC NC 67.2 (8.2) NC 29.4 (0.9)
43 AD AD 73.8 (8.5) AD 24.6 (2.9)
all significant
Triebel et al. [32] 2009 Petersen 87 MCI ADcon 74.4 (6.0) ADcon 27.0 (1.9) FCI NC >MCI; ADnon versus
NC: d = 0.83, ADcon versus
NC: d = 1.831.5 SD
below
(25 ADcon,
62 ADnon)
ADnon 68.5
(7.5)
ADnon 28.6
(1.4)
76 NC NC 66.7 (8.5) NC 29.4 (1.0)
Management of everyday technology: performance-based instruments
Malinowsky et al. [53] 2010 Petersen 33 MCI MCI 70.5 (8.4) MCI 27.5 (1.9) META NC >MCI > AD, MCI versus
NC: d = 0.66, MCI versus AD:
d = 1.2345 NC NC 73.2 (9.7) NC 29.3 (1.1)
38 AD AD 75.3 (9.1) AD 23.5 (3.3)
Malinowsky et al. [38] 2012 Petersen/
Winblad
33 MCI MCI 70.8 (8.6) MCI 27.5 (1.9) META NC > AD, MCI = NC
42 NC NC 72.6 (9.7) NC 29.4 (1.0)
35 AD AD 75.5 (9.2) AD 23.5 (3.4)
ns
Management of everyday technology: informant-report rating instruments
Munoz-Neira et al.
[54]
2012 Winblad 21 MCI MCI 71.3 (9.1) MCI 26.1 (2.5) T-ADLQ Total score: NC >MCI > AD,
MCI versus NC: d = 0.62,
MCI versus AD: d = 1.47
Subscales: NC > MCI on 2
subscales: employment and
recreation: d = 0.54, travel:
d = 0.55
44 NC NC 74.1 (7.3) NC 27.8 (2.3)
63 AD AD 73.9 (8.7) AD 17.9 (5.8)
Management of everyday technology: self-report rating instruments
Nygård et al. [55] 2011 Petersen/
Winblad
37 MCI MCI 67.0 (7.47) MCI 27.5 (2.1) ETUQ (support of proxy
possible for patients
with AD and MCI)
Perceived relevance of ET:
NC >MCI > AD; MCI versus
NC: d = 0.51, MCI versus AD:
d = 1.26
44 NC NC 69.0 (9.58) NC 29.1 (1.1)
37 AD AD 72.0 (8.92) AD 25.4 (2.8)
ns ns Perceived difficulty of ET:
NC <MCI < AD; MCI versus
NC: d = 0.82, MCI versus AD:
d = 1.26
Rosenberg et al. [56] 2009 Petersen 30 MCI MCI 74.0 (6.9) MCI 27.0 (2.4) ETUQ (support of proxy
possible for patients
with AD and MCI)
Perceived relevance of ET:
NC >MCI = AD; MCI versus
NC: d = 1.6693 NC NC 74.0 (7.6) NC 28.0 (1.7)
Perceived difficulty of ET:
NC <MCI < AD; MCI versus
NC: d = 0.59, MCI versus AD:
d = 1.00
34 AD AD 73.0 (8.4) AD 24.0 (3.3)
ns
Driving capacity: performance-based instruments
Wadley et al. [51] 2009 Petersen 46 MCI MCI 71.3 (7.8) Not reported UAB-DA MCI < NC, d = 0.46
59 NC NC 67.1 (6.7)
significant
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events, taking part in a conversation, taking a message,
doing two tasks at a time, coping with unfamiliar situa-
tions and performing a task while under pressure. Con-
ducting a factor analysis, the authors further subdivided
the items into IADL with high or low cognitive demands.
Group differences emerged only for the high cognitive
demand factor, which consisted mainly of the items
mentioned above, which in turn were responsible for the
group differences between healthy controls and MCI sub-
jects. The low cognitive demand factor consisted of items
such as shopping, using transportation and preparing
food. The same work group [28] gathered longitudinal
data and again found differences in the Bayer-ADL scale
between patients with MCI and healthy controls at
baseline and at 2-year follow-up. For healthy controls,
Bayer-ADL items with high cognitive demand predicted
conversion to MCI and dementia at follow-up. Using
the Functional Activities Questionnaire (FAQ), Brown
et al. [15] detected significant differences between pa-
tients with MCI and healthy controls, and patients with
MCI showed more deficits than healthy controls re-
garding financial skills and remembering events.
With the exception of one study [42], differences be-
tween patients with MCI and healthy controls were con-
sistently detected. Deficits regarding financial abilities
and memory-related IADL such as keeping appointments
or remembering events were common themes across
studies. With large effect sizes and consistent results
across studies, the informant-reported ADCS-MCI-
ADL seems to be a useful tool for global IADL assessment.
The Lawton and Brody IADL scale delivered mixed
results. Jefferson et al. detected no significant differ-
ences between MCI and healthy controls [43], whereas
Pedrosa et al. found large effects [45] and Mariani
et al. discovered small effects [44]. The same holds
true for the Bayer-ADL. Large effects were seen in the
two studies by Perneczky et al. [46,47], but only small
effects were reported in the studies by Reppermund
et al. [28,29].
Self-report rating instruments
Using the Seoul-IADL in a self-rating version, Kim et al.
[36] found patients with MCI to be significantly im-
paired in using a telephone, keeping appointments,
talking about recent events and using household appli-
ances, thus replicating the findings of Ahn et al. with
the Seoul-IADL in an informant-rating version [41]. In
addition, Kim et al. also reported worse performance of
the MCI group for transportation and finances. Peres
et al. [27] investigated restriction to four IADL items
from the Lawton and Brody IADL scale in a self-rating
version: telephone use, mode of transport, medication
responsibility and handling finances. Patients with MCI
were more often restricted in IADL (34.3%) than con-
trols (5.4%) and were less restricted than patients with
dementia (91.1%). Interestingly, within a 2-year period,
IADL-restricted patients with MCI converted to dementia
more frequently than IADL-nonrestricted patients with
MCI (30.7% versus 7.8%).
Table 3 Studies investigating specific instrumental activities of daily living domainsa (Continued)
Driving capacity: self-report rating instruments
O’Connor et al. [59] 2010 Petersen/
Winblad
304 MCI MCI 76.8 (6.5) Not reported DHQ (aMCI = naMCI =mdMCI) <
NC (driving frequency,
driving difficulty, driving
space) differed at baseline
and faster rates of decline
Driving frequency: aMCI
versus NC: d = 0.31, naMCI
versus NC: d = 0.24, mdMCI
versus NC: d = 0.14
Driving difficulty: aMCI
versus NC: d = 0.35, naMCI
versus NC: d = 0.36, mdMCI
versus NC: d = 0.45
Driving space: aMCI versus
NC: d = 0.42, naMCI versus
NC: d = 0.51, mdMCI versus
NC: d = 0.43
1.5 SD
below
(82 aMCI NC 72.6 (5.3)
140 naMCI significant
82 mdMCI)
2,051 NC
Shopping capacity: performance-based instruments
Werner et al. [52] 2009 Petersen 30 MCI MCI 69.3 (7.4) MCI 27.5 (1.3) VAPS MCI < NC; significant
subscales: distance d = 0.29,
trajectory duration: d = 1.16,
duration of pauses: d = 0.89
30 NC NC 69.6 (7.3) NC 29.4 (0.7)
ns significant
aAD, Alzheimer’s disease; ADcon, Converters to Alzheimer’s disease; ADnon, Nonconverters to Alzheimer’s disease; aMCI, Amnestic mild cognitive impairment, both
single and multiple domains; CDR, Clinical dementia rating; DHQ, Driving Habits Questionnaire; ETUQ, Everyday Technology Use Questionnaire; FCI, Financial
Capacity Instrument; MCI, Mild cognitive impairment; mdMCI, Multiple-domain mild cognitive impairment; NC, Normal control; ns, Nonsignificant; UAB-DA,
University of Alabama at Birmingham Driving Assessment; VAPS, Virtual Action Planning Supermarket.
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Global instrumental activities of daily living and mild
cognitive impairment subtypes
When we analyzed MCI subtypes, differences between
MCI subtypes and normal controls were reported for all
applied measures except of the Lawton and Brody IADL
scale. Looking at effect sizes, the IADL deficits tended to
be more pronounced in multiple-domains MCI than in
single-domain MCI and also in amnestic MCI than in
nonamnestic MCI.
Informant-report rating instruments
Focusing on MCI subtypes, Tam et al. [48] found that
the multiple-domains MCI subgroup had an intermedi-
ate IADL performance level between those of normal
controls and patients with mild dementia on the Disa-
bility Assessment for Dementia (DAD) scale. Using the
DAD, IADL performance, as well as subjects’ perform-
ance regarding initiation or planning and organizing of
the IADL subtasks, can be evaluated. The amnestic MCI
group had significantly better IADL scores than the
multiple-domains MCI group, and their scores were
similar to those of the cognitively normal controls. The
IADL subscales most frequently impaired in the
multiple-domains MCI group were those connected to
planning and organizing IADL tasks; initiation of tasks
was unaffected.
Aretouli et al. [23] found significant differences
between healthy controls and patients with MCI for 12
of 15 items on the Activities of Daily Living-Prevention
Instrument. Major difficulties were reported for keep-
ing appointments, using the telephone, remembering
current events and finding things at home, and minor
difficulties were reported for driving and using trans-
portation, managing finances, organizing and complet-
ing activities, and taking medication. An analysis of the
MCI subtypes revealed that all four subgroups showed
deficits compared with normal controls. However, patients
with multiple-domains MCI were not significantly differ-
ent from those with single-domain MCI, and the amnestic
groups did not differ significantly from the nonamnestic
groups.
Using the DAD, Yeh et al. [33] reported more IADL
deficits for both single-domain amnestic MCI und
multiple-domains amnestic MCI than for healthy con-
trols. Both MCI groups had better DAD scores than the
mild AD group. When they looked at the DAD scores
in detail, though, multiple-domains amnestic patients
with MCI had deficits on a larger number of items than
single-domain amnestic patients with MCI. Applying
the DAD-6 (a shortened version of the DAD), de Rotrou
et al. [40] reported similar findings. Using the FAQ,
Teng et al. [31] reported better results for normal con-
trols than for patients with MCI. In analyzing the sub-
groups, they found better results for normal controls
than for the amnestic MCI group on all investigated
IADL items and better scores than the nonamnestic
group on managing bills, preparing taxes, keeping up
with current events, attending to media, remembering
dates and traveling outside the neighborhood. Luck
et al. [58] investigated performance on nine IADL
items and detected worse performance of patients with
MCI compared with healthy controls. Analyses of MCI
subtypes revealed that this effect was stronger for amnes-
tic MCI subtypes.
Self-report rating instruments
Investigating MCI subtypes and normal controls, Wadley
et al. [61] found all MCI subgroups reported significantly
greater IADL difficulty and worse everyday functioning
scores than normal controls at baseline. Over a 3-year
period, all MCI groups also showed a significantly steeper
decline on the everyday-functioning composite score and
IADL performance compared with the cognitively normal
group.
One study comparing all three assessment modalities
In a study by Burton et al. [37], three different IADL
measures were used that revealed differences between
MCI subtypes and healthy controls on the Scales of
Independent Behavior–Revised (on both the self- and
informant-report version) and the performance-based
Everyday Problems Test. No differences between groups
emerged with the use of Lawton and Brody’s IADL scale
with either the self-report or the informant-report version.
Specific instrumental activities of daily living domains
Financial capacity performance-based instruments
Financial capacity is the best-studied IADL subdomain.
The Financial Capacity Instrument (FCI) has been used
in three studies [26,30,32]. The FCI assesses financial
capacity in seven domains, including monetary skills,
financial concepts and bank statement management. All
three studies revealed that the overall financial capacity
(total score) of patients with MCI was worse than that of
healthy controls. The activity “bank statement manage-
ment” was consistently affected across studies. Griffith
et al. [26] additionally found group differences regarding
bill payment and financial concepts. Moreover, Triebel
et al. [32] reported longitudinal data showing that, at
baseline, MCI participants were significantly worse than
normal controls on all financial domains and on total
scores. Furthermore, the MCI group had been divided
into converters and nonconverters to dementia. At base-
line, the MCI nonconverter group performed better than
the converter group in the domains of financial con-
ceptual knowledge, cash transactions, bank statement
management, bill payment and both total scores. No
differences were observed for the domains of basic
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monetary skills, checkbook management, financial judg-
ment and investment decision-making. Over a 1-year
period, declines in the domain checkbook management
and the total score were observed for the converters, but
not for the nonconverters or controls [32].
Management of everyday technology
Performance-based instruments In 2010, Malinowsky
et al. [53] used a standardized observation-based tool
(Management of Everyday Technology Assessment) to
evaluate ability to manage everyday technology (ET; for
example, electronic household appliances, remote con-
trols, cell phones) in patients with mild AD or MCI and
controls. They found significant differences between all
three groups. Patients with MCI performed worse in
using technology than healthy controls did, but better
than patients with dementia. In a more recent analysis
of the same sample by the same work group [38], signifi-
cant differences were observed only between healthy
controls and patients with dementia when intrapersonal
and environmental features were controlled for. They
reasoned that what influences a person’s ability to use
ET—besides cognitive level or diagnosis—is within-
person variability in intrapersonal characteristics and
environmental influence (that is, the design of the ET
and the context in which it is used).
Informant-rating instruments Muñoz-Neira et al. [54]
added a technology subscale to a Spanish ADL question-
naire. They found significant group differences between
healthy controls, patients with MCI and patients with
dementia for the total score. Patients with AD had worse
scores than patients with MCI and healthy controls on
all seven subscales. Comparing patients with MCI and
healthy controls, only the recreation and travel subscales
differed significantly; no difference was observed for the
technology subscale.
Self-report rating instruments Applying the Everyday
Technology Use Questionnaire, Rosenberg et al. [56]
investigated the perceived difficulty in use of everyday
technologies in samples with AD, MCI and controls.
They found significant differences between groups, as
well as in the amount of technologies that were consid-
ered relevant in each group. Using the same instrument,
Nygård et al. [55] could replicate the above-mentioned
findings. Furthermore, they found a moderately strong
association between engagement in everyday life activities
and perceived difficulty in ET use in these three samples.
Driving capacity
Performance-based instruments Wadley et al. [51] in-
vestigated driving ability, which revealed that patients with
MCI were significantly more likely than participants who
were cognitively normal to be given “less than optimal”
ratings for left-hand turns, lane control and the global
driving rating. Furthermore, they tended to receive more
“less than optimal” ratings on gap judgment and maintain-
ing proper speed. No differences were found for right-
hand turns or steering steadiness. The authors noted,
however, that the magnitude of difference between MCI
participants’ driving performance and that of controls was
small, and that, as a group, MCI drivers were not suffi-
ciently impaired to have their driving ability rated as
unsafe or unsatisfactory.
Self-report rating instruments O’Connor et al. [59] in-
vestigated 5-year trajectories of mobility indicators, in-
cluding driving frequency and perceived driving difficulty.
The study revealed that driving frequency had a steeper
decline in the MCI group compared with healthy controls.
Furthermore, driving in both normal and demanding
situations was perceived as more difficult by patients with
MCI than controls.
Shopping capacity performance-based instruments
Werner et al. [52] directly assessed the IADL domain of
shopping by means of a virtual reality supermarket sce-
nario (the Virtual Action Planning Supermarket). They
found that patients with MCI covered a significantly
higher mean distance, had longer pauses and accordingly
took longer to complete their shopping than normal
controls. However, the number of purchases, correct or
wrong actions, stops and mean time to pay did not differ
between groups.
Discussion
This review impressively illustrates that deficits in IADL
are consistently present in MCI. Of the 37 included
studies, 35 revealed deficits in global IADL or in specific
IADL subdomains such as finances, shopping, keeping
appointments, driving or ET use. Furthermore, compared
with healthy controls, patients with MCI needed longer to
complete tasks and tended to be less accurate. Effect sizes
were predominantly moderate to large. In analyzing the
MCI subtypes, we observed that the IADL deficits tended
to be more pronounced in multiple-domains MCI than in
single-domain MCI and in amnestic MCI than in nonam-
nestic MCI, respectively.
In general, patients with MCI had intermediate func-
tional performance between healthy controls and pa-
tients with mild AD, particularly in more complex tasks
with high cognitive demand. Financial capacity, particu-
larly, was affected in a vast majority of studies. On the
general IADL questionnaires, telephone use, responsibil-
ity for medication and keeping appointments were the
domains most often affected. Nevertheless, there were
studies that revealed no deficits in these domains [37,42].
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Even when comparing studies in which researchers used
the same instrument, such as the Seoul-IADL [36,41],
only three matching domains emerged: telephone use,
keeping appointments and using household appliances.
Similar inconsistencies were observed for Lawton and
Brody’s IADL Scale [5]. In two studies in which this in-
strument was used, investigators did not find any differ-
ences between patients with MCI and persons who were
cognitively normal [37,43], supporting the argument that
this scale is not sensitive enough to detect subtle defi-
cits in MCI. However, researchers in two other studies
[44,45] used the same scale and identified impairments in
patients with MCI regarding the domains of shopping,
medication and finances. One possible explanation for
these inconsistencies is the very heterogeneous operatio-
nalization of the MCI criteria. Some studies relied solely
on a clinical decision, and others used cutoff scores to
determine the magnitude of cognitive impairment, but
even the cutoff scores varied between 1 SD and 1.5 SD
below age- and education-adjusted norms. Furthermore,
the mean MMSE scores of MCI subjects ranged from
23.1 [36] to 28.7 points [37], and mean MMSE scores of
normal controls ranged from 26.5 [36] to 29.4 points
[30]. The problem with studies including patients with
MCI with very low MMSE scores is that IADL deficits
may be due to already present, but not yet diagnosed,
dementia. In a long-term study of patients with mild AD
(MMSE score range, 20 to 26), 45% to 65% could not per-
form usual IADL tasks at baseline, and 70% to 85% of the
remaining patients needed assistance with IADL after
3 years [81]. For future research, it would be helpful to
conduct (sub)analyses with patients with MCI who have
a MMSE score of 27 points or higher to ensure that they
have not already converted to dementia. Another possi-
bility is to use cutoff scores of 1 SD, instead of 1.5 SD,
below age- and education-adjusted norms in neuro-
psychological tests [82]. Moreover, it should be taken into
consideration that the MMSE is a rather insensitive
measure for cognitive functioning, as it is not adjusted
for age and education. In general, the use of MMSE
cutoff scores to define MCI should be scrutinized.
In reviewing the selected articles, we found that the
variety of assessment instruments applied to assess IADL
in MCI was impressive; 31 different instruments were
identified (see Table 1), which complicates comparisons
among studies. Another problem is that few of these
instruments were constructed and validated for IADL
assessment in patients with MCI. The majority of the
instruments used were originally designed for studies with
patients with dementia, and thus the items are not cali-
brated to detect subtle differences from normal. Moreover,
data on psychometric properties are mainly insufficient;
for an overview of IADL scales in dementia where the
need for validation studies is explicated, see the article by
Sikkes et al. [83]. Measures specifically designed for MCI
populations are required. This may be exemplified by the
failure of the ADCS-ADL scale to reveal differences
between patients with MCI and healthy controls [25],
whereas the ADCS-MCI-ADL scales definitely detected
differences [46,47]. The problem could be solved by con-
structing more sensitive item scoring for MCI-specific
scales and/or by investigating in detail only those domains
that have been shown to be impaired consistently in MCI,
such as financial capacity. When the domain of financial
capacity was thoroughly analyzed by an interview or a
performance-based assessment procedure, differences
between patients with MCI and control participants
with cognitive impairment were persistently observed
[26,32,39] and invariably revealed large effect sizes.
Furthermore, the majority of assessment instruments
do not investigate computer skills or the handling of
“new” technology in general. The instruments targeting
ET use are examples of scales that focus on a particular
domain that proved to be sensitive to subtle impairment,
and significant differences were detected through both
self-reports and observations [53-56].
Performance-based assessment methods seem to be a
promising tool, especially for patients without proxies to
provide information about the patient’s IADL. Moreover,
performance-based methods would overcome another
methodological issue related to self- and/or informant-
report measures. In three reviewed studies [15,25,44],
healthy controls rated their IADL capacity themselves,
whereas MCI subjects were rated by their proxies. This
inconsistency could lead to biased results, as rating
procedures differed. All assessment methods have their
limitations. When using self-report, patients tend to
over- or underestimate their abilities and may not have
full insight into the impairments caused by the disease.
Informant-based methods rely on the informant’s know-
ledge about the patient, which might be affected by the
amount of care provided. In addition, family members
tend to misjudge the patient’s capacity. Performance-
based instruments also have limitations, such as a higher
degree of training needed by assessors, a more time-
consuming evaluation and an unfamiliar environment that
might bias the functional performance [84].
Furthermore, this review revealed some main prob-
lems of MCI definition. The operationalization of MCI
is not clearly specified, which leads researchers to define
cutoff points and choose assessment instruments of their
own. The new criteria for prodromal AD/MCI due to
AD may overcome this problem by including biomarkers
for the diagnosis of the condition [85]. Nevertheless, the
differentiation between MCI and dementia, as described
in the new National Institute on Aging and Alzheimer’s
Association criteria, rests on the determination of whe-
ther there is significant interference in the ability to
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function at work or in usual daily activities [86]. There-
fore, the identification of IADL deficits in MCI as an
early phase of AD is absolutely essential for clinical prac-
tice. Regarding the effect sizes, the differences between
MCI subjects and healthy controls are not only statis-
tically significant but also clinically relevant and can be
considered quite robust. Defining a threshold of functional
impairment, however, remains a difficult task. MCI is pri-
marily a neuropsychologically defined construct. To give
recommendations on exact thresholds, IADL measures
which are specifically designed for and/or validated in
MCI populations are needed first. If this is achieved, fu-
ture criteria for MCI could postulate mild deficits in IADL
functioning (that is, more than 1.5 standard deviations
below healthy controls) in at least one of the following do-
mains: financial abilities, keeping appointments, task com-
pletion time, task accuracy or remembering recent events.
It appears evident on the basis of this review that patients
with MCI with IADL deficits are more likely to convert to
dementia than are patients with MCI without IADL restric-
tions [27,32]. In fact, the presence of acquired IADL disabi-
lity not due to a concomitant physical condition seems to
be in itself a valid marker of prodromal AD. Studies asses-
sing structural brain functioning and IADL impairment in
MCI simultaneously [87] can help to identify relevant
biomarkers of IADL deficits and at-risk individuals. Failure
to detect an individual’s functional impairments might pre-
clude training of these activities by occupational therapy
or lead to neglecting needs and providing an inadequate
amount of care from community-based services. Deterior-
ation in IADL abilities, rather than cognition impairments,
predicted a greater need of home help services in AD [88].
Conclusions
Although there was no uniform agreement about which
IADL domains are typically—that is, characteristically
and/or specifically—impaired in MCI and which types of
instruments may detect those best, a clear tendency never-
theless emerged, with activities requiring higher cogni-
tive processes being consistently affected. Also, the use
of performance-based measures and technology-related
items seems to be promising.
Future research should concentrate on both the thorough
validation of established instruments and the development
of new ones. As new instruments for IADL functioning in
MCI are being developed, researchers should include items
measuring the domains of financial capacities, keeping
appointments, task completion time and task accuracy.
Moreover, studies comparing the three assessment mo-
dalities—that is, self-report, informant-report rating and
performance-based—in the same sample are needed. In
the long run, this could lead to a more precise definition
of functional impairment in MCI in terms of quantifiable
cutoff scores.
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